After food intake, the intestine releases GLP-1 and GIP, which stimulate insulin secretion from pancreatic -cells and inhibit glucagon secretion from pancreatic -cells (glucagon is a hormone that increases blood sugar levels)
Glucagon-receptor: Bestudeerd vanwege de invloed op het energieverbruik van het lichaam
Thiazide and loop diuretics (like hydrochlorothiazide and furosemide) waste potassium through the urine, increasing the risk of hypokalemia the same direction GLP-1 GI losses push
However, unlike other peptides similar to it (Tesamorelin, etc), Ipamorelin is less likely to influence appetite
Furthermore, cost-effectiveness analyses specific to semaglutide in CKD remain limited, particularly in comparison to established therapies such as SGLT2is, which have demonstrated substantial healthcare savings when applied to cardio-kidney-metabolic populations[74]